Adel Mahmoud, M.D., Ph.D. serves as Chairman of ILiAD’s Scientific Advisory Board and provides extensive experience as a vaccine industry business executive, as well as expertise in vaccine science and development. Dr. Mahmoud is currently a Professor in the Department of Molecular Biology at Princeton University and at the Woodrow Wilson School of Public and International Affairs.

From 1999 to 2005, Dr. Mahmoud was President of Merck Vaccines and served as a member of the Management Committee of Merck & Company, Inc. At Merck, he also served as Chief Medical Advisor for Vaccines and Infectious Diseases. Dr. Mahmoud’s leadership resulted in Merck’s formidable vaccine portfolio, including commercialization of new vaccines for rotavirus, human papillomavirus, and shingles; and commercialization of a new combination vaccine for measles, mumps, rubella, and varicella.

His prior academic services at Case Western Reserve University and University Hospitals of Cleveland spanned 25 years concluding as Chairman of Medicine and Physician-in-Chief from 1987 to 1998. He is past President of the International Society for Infectious Diseases and former Chair of the Board of Scientific Counselors of the U.S. National Center for Infectious Diseases.